In the battle against cancer, early detection is crucial for timely medical interventions when the chances of survival are highest. Unfortunately, traditional cancer testing methods that rely on symptom-based diagnosis can result in almost 50% of patients being diagnosed in advanced stages, leading to the need for more aggressive treatments and less favorable outcomes. LucenceINSIGHT™, now available through Health Today, offers Canadians access to state-of-the-art screening technologies for early cancer detection. This pioneering test has the potential to reduce the incidence of late-stage diagnosis and empower individuals to take control of their health and well-being.
Early detection of cancer signatures and prompt diagnosis provides significant benefits to patients, including:
Yet, despite the availability of early detection technologies, 40% of screenable cancers are still diagnosed at advanced stages, highlighting the need for greater awareness and proactive screening measures.
Introducing LucenceINSIGHT™
Health Today Inc. proudly introduces LucenceINSIGHT™, a groundbreaking multi-cancer early detection (MCED) tool designed to revolutionize cancer care for Canadians. By harnessing a simple blood draw, LucenceINSIGHT™ screens for the signal of up to 50 cancers with unprecedented precision. Thanks to its proprietary amplicon-based technology, the tool boasts an impressive sensitivity of 80.9% and specificity of 99%, identifying critical single nucleotide variations (SNVs), indels, and cancer-associated viruses such as Epstein-Barr virus (EBV) and Human Papillomavirus (HPV) in circulating tumor DNA (ctDNA).
What sets LucenceINSIGHT™ apart is its innovative use of data to generate a localization signal, predicting with 88% accuracy the potential origins of the cancer signal within the body. This feature, known as Predicted Signal Localization, is a game-changer, offering valuable insights that direct further confirmatory diagnostic testing. For Canadians, LucenceINSIGHT™ offers a beacon of hope, enabling earlier detection of cancer when treatment is most effective, significantly enhancing the prospects of successful outcomes and transforming the landscape of cancer care in the country.
LucenceINSIGHT™ testing is a powerful comprehensive cancer screening tool that can benefit anyone who wants a comprehensive snapshot of their health and disease risk, and certain populations are likely to benefit the most from this innovative technology. LucenceINSIGHT™ testing can provide critical insights into overall health and guide more effective treatment decisions for Canadian with increased risk for cancer including:
Ground-Breaking Detection Of These Cancers With LucenceINSIGHT™
LucenceINSIGHT™ utilizes the amplicon-based technology to screen multiple cancers. This test correctly identifies cancer 80.9% of the time and correctly ruling it out 99% of the time. It can spot tiny genetic changes and certain viruses linked to cancer in DNA that comes from tumors and is found in the bloodstream.
After analyzing this information, the test can also guess where in the body these cancer signs started, suggesting up to two possible locations. These predictions are called Predicted Signal Localization and are included in the results provided by LucenceINSIGHT™. This innovative cancer screening test is capable of detecting signatures of 12 types of cancer, including:
Health Today also offers LucenceINSIGHT™ PLUS, which screens for up to 50 cancer types and provides a more comprehensive range of cancer detection. LucenceINSIGHT™ covers the 12 cancers highlighted in green.
Early detection of these cancers can increase 5-year survival rates to as high as 99%. The following are some examples of the significant increases in survival rates that can result from early detection.
Early vs. Late Cancer Diagnosis 5-Year Survival Rates
| Cancer Type | 5-Year Survival (Localized) | 5-Year Survival (Distant) |
|---|---|---|
| Breast Cancer | 99% | 28% |
| Ovarian Cancer | 93% | 31% |
| Cervical Cancer | 92% | 17% |
| Endometrial | 95% | 17% |
| Colorectal Cancer | 91% | 14% |
| Bladder Cancer | 96% | 6% |
| Stomach Cancer | 70% | 6% |
| Liver Cancer | 34% | 3% |
| Prostate Cancer | 99% | 30% |
How Does LucenceINSIGHT™ Testing Work?
LucenceINSIGHT™ works by conducting a single blood test to screen for signatures of multiple cancers, including breast, ovarian, cervical, pancreatic, liver, colorectal, stomach, prostate, and bladder cancers, (when applicable). After collecting your sample, The Health Today team ships to a lab for processing. Results are provided in 7-10 days for LucenceINSIGHT™, and 14-21 days for LucenceINSIGHT™ PLUS.
Early detection of cancer results in less invasive interventions, lower disease progression, higher survival rates, and ultimately better quality of life. With LucenceINSIGHT™, you can gain comprehensive insight into your risk of cancer and serious diseases. Armed with this science-backed data, you can make informed decisions about your lifestyle, treatments, and overall health and wellness. Don't wait for symptoms to appear, take control of your health today with LucenceINSIGHT™. For more information, book your LucenceINSIGHT™ Cancer Screening online through Health Today.
LucenceINSIGHT™ uses proprietary amplicon-based next-generation sequencing (NGS) technology to screen for the signal of 50 cancers with a sensitivity of 80.9% and specificity of 99%. The test identifies single nucleotide variations (SNVs), indels and cancer associated viruses such as Epstein-Barr virus (EBV) and Human Papillomavirus (HPV) in circulating tumor DNA (ctDNA).
When a cancer-associated finding is made, the machine-learning algorithm analyzes the data to predict up to 2 sites where the cancer signal might have originated from. The report will present the result as Predicted Signal Localization, with an accuracy of 88%.
LucenceINSIGHT™ is recommended in conjunction with existing screening tools for:
Note: LucenceINSIGHT™ is not recommended for use in individuals who are pregnant, or have a history of cancer in the past 3 years.
After collecting your sample, The Health Today team ships to a lab for processing. Results are provided in 7-10 days for LucenceINSIGHT™, and 14-21 days for LucenceINSIGHT™ PLUS.
Health Today is now able to provide Canadians with LucenceINSIGHT™, and LucenceINSIGHT™ PLUS for up to 50 cancers from a single blood test. Book an appointment, today.
Contact us below and someone from our team will connect with you right away. We look forward to the opportunity to serve you.
